Your browser version is outdated. We recommend that you update your browser to the latest version.

DeNovX Initiates Strategic R&D Collaboration with Scientists at SLAC National Accelerator Laboratory, Operated by Stanford University

Posted 3/22/2021

DeNovX is pleased to announce that it has executed a collaborative agreement to advance the development of high throughput compressive cocrystallization with detection by synchrotron powder X-ray diffraction with SLAC National Accelerator Laboratory, which is operated by Stanford University for the Department of Energy. This effort targets improvements to the solubility and bioavailability of active pharmaceutical ingredients, and it is sponsored by the National Institutes of Health through a Phase II SBIR award to DeNovX.